Evidence map›Paper›PMID 41200858›Full record

ArticleGut microbes2025

Zhan Huang, Loic Brot, Rand Fatouh, Marius Bredon, Laura Creusot, Antoine Lefèvre, Antonin Lamazière, Jérémie H Lefevre, Patrick Emond, Julien Planchais and 3 more

Abstract read
In one paragraph

Article in Gut microbes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Gut microbes · 2026
    Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zhan HuangSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France.
Loic BrotSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France.
Rand FatouhSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France.
Marius BredonSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France.
Laura CreusotSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France.ORCID 0000-0002-3882-8423
Antoine LefèvreINSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, Université de Tours, Tours, France.
Antonin LamazièreSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France.
Jérémie H LefevreGut, Liver & Microbiome Research (GLIMMER) FHU, Paris, France.
Patrick EmondINSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, Université de Tours, Tours, France.
Julien PlanchaisResearch and Development Center, Biocodex, Compiègne, France.
Xavier RouxResearch and Development Center, Biocodex, Compiègne, France.
Harry SokolSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France.
Nathalie RolhionSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The probiotic

Indexed as

Anti-Bacterial AgentsGastrointestinal MicrobiomeProbioticsSaccharomyces boulardiiAmoxicillin-Potassium Clavulanate CombinationBacteriaCytokinesDysbiosisHumansIntestinal MucosaLeukocytes, MononuclearVancomycinAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial AgentsCytokinesVancomycinantibioticgut microbiomeimmune responsemetabolomicsquantitative microbiota profilingSaccharomyces boulardii CNCM I-745

Identifiers

PMID41200858
PMCPMC12599567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.